Commonwealth Coat of Arms of Australia

 

 

 

 

 

 

PB 142 of 2025

 

National Health (Originator Brand) Amendment Determination (December update) 2025

 I, Rebecca Richardson, Assistant Secretary, PBS Listing, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, Disability and Ageing, delegate of the Minister for Health and Ageing, make the following Determination.

Dated              27    November 2025  

REBECCA RICHARDSON

Assistant Secretary

PBS Listing, Pricing and Policy Branch

Technology Assessment and Access Division

Department of Health, Disability and Ageing


1  Name

2  Commencement

3  Authority

4  Schedules

Schedule 1—Amendments

National Health (Originator Brand) Determination 2025 (PB 114 of 2025)

 

 

  This instrument is the National Health (Originator Brand) Amendment Determination (December Update) 2025.

  This instrument may also be cited as PB 142 of 2025.

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

 1 December 2025

 

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

  This instrument is made under subsection 99ADB(6B) of the National Health Act 1953.

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

1  Schedule 1, (after table item 114)

Insert:

 

114A

Drospirenone

Slinda

 

 

2  Schedule 1, (after table item 126)

Insert:

 

126A

Eribulin

Halaven

 

 

3  Schedule 1, (after table item 176)

Insert:

 

176A

Haloperidol

Serenace

 

 

4  Schedule 1, (after table item 286)

Insert:

 

286A

Pazopanib

Votrient

 

 

5  Schedule 1, (after table item 369)

Insert:

 

369A

Tranylcypromine

Parnate